Biosenta Inc.
ZRO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 200.00% | -48,800.00% | 146,200.00% | 0.00% | -50.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.00% | -48,800.00% | 146,200.00% | 0.00% | -50.00% |
| Cost of Revenue | 0.00% | 0.00% | -96.15% | 0.00% | 0.00% |
| Gross Profit | 100.00% | -146,300.00% | 5,952.00% | -- | 0.00% |
| SG&A Expenses | -1.93% | -23.53% | -24.59% | -49.26% | 0.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.22% | -29.82% | -23.46% | -45.16% | -0.55% |
| Operating Income | -0.05% | -19.00% | 63.33% | 45.22% | 0.49% |
| Income Before Tax | -21.20% | 86.56% | -8.67% | -47.47% | -94.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.20% | 86.56% | -8.67% | -47.47% | -94.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.20% | 86.56% | -8.67% | -47.47% | -94.33% |
| EBIT | -0.05% | -19.00% | 63.33% | 45.22% | 0.49% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1.53% | 85.09% | 13.13% | -24.07% | -70.13% |
| Normalized Basic EPS | 1.22% | -77.59% | 13.00% | -23.53% | -70.83% |
| EPS Diluted | 1.53% | 85.09% | 13.13% | -24.07% | -70.13% |
| Normalized Diluted EPS | 1.22% | -77.59% | 13.00% | -23.53% | -70.83% |
| Average Basic Shares Outstanding | 22.65% | -9.94% | 24.82% | 19.44% | 15.02% |
| Average Diluted Shares Outstanding | 22.65% | -9.94% | 24.82% | 19.44% | 15.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |